The Sunday Telegraph reported on soaring nickel prices due to supply fears, which has meant that Albidon's (ALD) shares have been in hot demand. Production isn't expected until '08, with ABN Amro anticipating the mine to produce 19.5m pounds of nickel a year, at an estimated cash cost of $2 per lb. Some analysts and investors are scheduled to visit the Munali site, which could lead to revised expectations for the project. Albidon is a high-rsik bet, but interest in the company is unlikely to wane while the nickel price remains at its current levels. Speculative buy. Following this upbeat conclusion, the shares added 2.50p, reaching 74.00p.
The Independent on Saturday noted that shares in Oxford BioMedica (OXB) had benefited from rumours of a 70p-a-share bid. The piece went on that some believe GlaxoSmithKline might be interested, while others speculated that a licensing deal with a major pharmaceutical company might be near. This positive momentum continued in this morning’s session, where the share price added a further 4.00p to reach 50.00p.
Stanelco (SEO) appeared in Saturday’s Daily Express, which commented that traders reckon the Company may benefit from Wal-Mart’s efforts to become more environmentally friendly. The share price was 0.01p weaker at 1.34p this morning.
Tanfield (TAN) received much press attention over the last few days. The Weekend’s FT noted an upturn in the share price on news of its supply deal with M&S, while Saturday’s Independent mirrored this view. Today’s FT included an article reporting the race to become “Green Van Man”, as electric vehicles from 2 companies are arriving at M&S and Tesco in April. Tony Blair opened Tanfield’s HQ in Tyne and Wear on Friday and said “in the years to come, this operation is absolutely where the future will be.” Nevertheless, the share price remained unchanged earlier today.
John Teeling, co-founder of West African Diamonds (WAD) and African Diamonds (AFD) featured in a Q & A interview in Today’s Daily Telegraph.
The prices were taken between 9.11am 9.39am on Monday 5 February 2007.
The following companies, in which City Equities customers may have an interest, released announcements to the market this morning. These can be found by entering the relevant company name or ticker code in the search box on this site.
Cagney (CGNY): Directorate Change.
Cambridge Minerals (CMR): Acquisition of Partners 50% Holding in Patacancha Claims, Peru.
Coolabi (COO): Directorate Change.
EiRx Therapeutics (ERX): Promotion of Board Member.
Elcom International (ELCS): Issue of Equity.
Electric Word (ELE): Expansion of Sports Division.
Encore Oil (EO.L): Interim Results.
Essentially Group (ESN): Motorsport Update.
Mercator Gold (MCR): Notice of EGM.
Mincorp (MOP): Issue of Equity.
Nexus Management (NXS): Change of Advisor.
Qonnectis (QTI): Partnership with UK Utility.
Real Estate Investors (RLE): Acquisition.
ReGen Therapeutics (RGT): Research Update.
Screen FX (SFX): MallFX Contract Win.
SR Pharma (SPA): Research Update.
Supporta (SOR): Directorate Change.
Taihua (TAIH): License Deal Opens Korea.
Monday 5 February – Interim Results from Encore Oil (EO.L).
Tuesday 6 February – UK BRC Retail Sales Monitor (January).
Wednesday 7 February – UK Industrial Production and Manufacturing Output (December).
Thursday 8 February – Bank of England Interest Rate Decision.
Friday 9 February – UK Trade (December).
The next Penny Share Review will be posted on Monday, 12 February 2007.
Compiled by Chris Richards.
There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.
The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.